Search research articles
Contact Us
Filters
Showing results (291-300 of 377) with videos related to
Page
of 38
Sort By:
Therapeutic Advances in Medical Oncology
|
November 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance
Sara Pilotto, Lorenzo Belluomini, Federico Monaca, et al.
Journal of Personalized Medicine
|
April 3, 2021
Development of a Digital Research Assistant for the Management of Patients' Enrollment in Oncology Clinical Trials within a Research Hospital
Alfredo Cesario, Irene Simone, Ida Paris, et al.
The Oncologist
|
February 20, 2024
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial
Emilio Bria, Floriana Morgillo, Marina Chiara Garassino, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
November 2, 2022
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer
Ilaria Trestini, Alberto Caldart, Marco Cintoni, et al.
Breast (Edinburgh, Scotland)
|
February 7, 2020
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model
Luisa Carbognin, Michele Simbolo, Anna Caliò, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2025
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis
Federico Monaca, Igor Gomez-Randulfe, Gerard Walls, et al.
British Journal of Cancer
|
November 17, 2022
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation
Maria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
Journal of Personalized Medicine
|
August 29, 2024
Outcomes of Radiotherapy in Oligoprogressive Breast Cancer
Fabio Marazzi, Valeria Masiello, Armando Orlandi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 11, 2023
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies
Federica Miglietta, Maria Vittoria Dieci, Tommaso Giarratano, et al.
Journal of Personalized Medicine
|
December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
Armando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Page
of 38
Search research articles
Search
Showing results (291-300 of 377) with videos related to
Sort By:
Page
of 38
Therapeutic Advances in Medical Oncology
|
November 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance
Sara Pilotto, Lorenzo Belluomini, Federico Monaca, et al.
Journal of Personalized Medicine
|
April 3, 2021
Development of a Digital Research Assistant for the Management of Patients' Enrollment in Oncology Clinical Trials within a Research Hospital
Alfredo Cesario, Irene Simone, Ida Paris, et al.
The Oncologist
|
February 20, 2024
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial
Emilio Bria, Floriana Morgillo, Marina Chiara Garassino, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
November 2, 2022
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer
Ilaria Trestini, Alberto Caldart, Marco Cintoni, et al.
Breast (Edinburgh, Scotland)
|
February 7, 2020
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model
Luisa Carbognin, Michele Simbolo, Anna Caliò, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2025
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis
Federico Monaca, Igor Gomez-Randulfe, Gerard Walls, et al.
British Journal of Cancer
|
November 17, 2022
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation
Maria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
Journal of Personalized Medicine
|
August 29, 2024
Outcomes of Radiotherapy in Oligoprogressive Breast Cancer
Fabio Marazzi, Valeria Masiello, Armando Orlandi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 11, 2023
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies
Federica Miglietta, Maria Vittoria Dieci, Tommaso Giarratano, et al.
Journal of Personalized Medicine
|
December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
Armando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Page
of 38